Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1080-1088

  Hung, C F ^a   Hsu, K F ^a   Cheng, W F ^a   Chai, C Y ^a   He, L ^a   Ling, M ^a   Wu, T C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; FLT3 LIGAND; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL LYSATE; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; DRUG POTENCY; EXTRACELLULAR SPACE; FEMALE; GENE GUN; GENETIC CODE; GENETIC LINKAGE; HUMAN; HUMAN CELL; METASTASIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENDOPLASMIC RETICULUM; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY, ACTIVE; LINKAGE (GENETICS); LUNG NEOPLASMS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

EID: 0035110962     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Experimental vaccine strategies for cancer immunotherapy
2. DNA vaccines
3. Exposing the immunology of naked DNA vaccines
4. DNA vaccines
5. DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses
6. Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene
7. Dendritic cells and the control of immunity
8. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
9. FLT3 ligand induces the generation of functionally active dendritic cells in mice
10. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family
11. Biologic effects and potential clinical applications of Flt3 ligand
12. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells
13. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs
14. Flt3 ligand induces tumor regression and antitumor immune responses in vivo
15. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a routine breast cancer model
16. Flt3 ligand antitumor activity in a murine breast cancer model: A comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action
17. FLT3-ligand administration inhibits liver metastases: Role of NK cells
18. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer
19. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma
20. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
21. Gene gun-mediated, DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs
22. Targeting HPV-16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine HPV-16 E7expressing tumors
23. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
24. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma
25. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
26. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes
27. Engineering an intracellular pathway for MHC class II presentation of HPV-16 E7
28. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity
29. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement
30. The NK-1.1(-) mouse: A model to study differentiation of murine NK cells
31. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate antitumor immune responses in vivo
32. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific antitumor immunity
33. In vivo priming by DNA injection occurs predominantly by antigen transfer
34. Creating CTL targets with epitope-linked β2microglobulin constructs
35. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
36. A reassessment of the role of B7-1 in antitumor immunity
37. Mechanism of flt3 ligand expression in bone marrow failure: Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis
38. Humoral and cellular immunities elicited by HIV-1 vaccination
39. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: Cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization
40. Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: Involvement of IFN-γ
41. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization
42. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
43. Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: Definition of cytokine requirements and developmental intermediates
44. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: Implications for anticancer and antiviral therapy
45. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
46. Contribution of CpG motifs to the immunogenicity of DNA vaccines
47. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
48. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
49. Potential DNA vaccine integration into host cell genome
50. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1
51. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses